BEAM stock news · Beam Therapeutics Inc.
Get alerts for BEAM
Follow Beam Therapeutics Inc. (BEAM) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BEAMFree on the App Store and Google Play, or on the web.
ARK Invest has bought more shares of Pacific Biosciences and other biotech companies.
NeutralBeam Therapeutics was named among the companies ARK added to its holdings. The report gives no new company results or plans, so its business outlook is unchanged.
Check out these 10 stocks where more than 33% of shares are being bet against.
NeutralBeam Therapeutics had 38.98% of its available shares sold short. The article reports no change to its business, so its outlook is unchanged.
Ten stocks could surprise investors by jumping in price soon.
NeutralBeam shows 38.86% short interest in the list, which signals strong bearish bets and potential squeeze mechanics, leaving the company's situation unchanged by this piece.